Le Lézard
Classified in: Health, Business
Subjects: NPT, FNC, SVY, PSF

$4.2 million federal grant will expand injury prevention research across region


SEATTLE, July 16, 2019 /PRNewswire/ -- A $4.2 million grant to UW Medicine's Harborview Injury Prevention & Research Center (HIPRC) will support injury prevention projects around prescription opioid abuse, suicide, older adult falls, and pediatric concussion in Washington state and the region.

UW Medicine (PRNewsFoto/UW Medicine) (PRNewsfoto/UW Medicine)

With the grant from the Centers for Disease Control and Prevention, HIPRC became one of nine CDC-funded Injury Control Research Centers nationally and the only such designated center in the Pacific Northwest. The five-year grant will significantly support HIPRC's efforts to research injury and prevention, educate the next generation of injury prevention specialists, and translate findings into policies, programs and public outreach.

"With this federal support comes a clear mandate to continue and expand our mission of injury prevention and health equity in the Pacific Northwest and beyond," said Dr. Monica Vavilala, director of HIPRC and a professor of anesthesiology and pediatrics at the University of Washington (UW) School of Medicine. "We have found significant injury and outcome disparities associated with geography, socioeconomic class, race and ethnicity and other factors. Our goal will be to better understand these disparities and promote equity."

HIPRC prioritizes interdisciplinary approaches to understanding injury prevention and population health, and the grant will fund four interdisciplinary research projects led by HIPRC faculty and focused on pressing injury prevention needs:

The grant will also fund a community research project to be selected and mentored by HIPRC faculty.

In addition to specific research projects, the grant will support the center's continuing work in research, education, and outreach around injury prevention and control in a wide range of topics. Collaborative "cores" of faculty and staff within the center will focus on each component of HIPRC's mission, with the research core led by Rowhani-Rahbar; education core led by Dr. Fred Rivara, professor of pediatrics at the UW School of Medicine; and outreach core co-led by Megan Moore, the Sydney Miller Endowed Associate Professor in Direct Practice in the UW School of Social Work, and Dr. Beth Ebel, associate professor of pediatrics at the UW School of Medicine.

HIPRC was founded in 1985 with a mission to reduce the burden of injury through research, education and outreach. Partnerships between HIPRC and universities, government agencies, and nonprofit organizations have led to injury prevention projects around booster seat use, distracted driving, bicycle helmet use, window fall prevention, and many other topics. To learn more, visit Hiprc.org.

Media Contact:  Susan Gregg, UW Medicine, [email protected]; 206.616.6730

 

SOURCE UW Medicine


These press releases may also interest you

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 15:55
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...



News published on and distributed by: